Fatty acid metabolism, beta-ketoacyl synthase family
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 1, no: 9 |
| NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4I9B2
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0006082 | organic acid metabolic process | 3 | 2 |
| GO:0006629 | lipid metabolic process | 3 | 2 |
| GO:0006631 | fatty acid metabolic process | 4 | 2 |
| GO:0006633 | fatty acid biosynthetic process | 5 | 2 |
| GO:0008152 | metabolic process | 1 | 2 |
| GO:0008610 | lipid biosynthetic process | 4 | 2 |
| GO:0009058 | biosynthetic process | 2 | 2 |
| GO:0009987 | cellular process | 1 | 2 |
| GO:0016053 | organic acid biosynthetic process | 4 | 2 |
| GO:0019752 | carboxylic acid metabolic process | 5 | 2 |
| GO:0032787 | monocarboxylic acid metabolic process | 6 | 2 |
| GO:0043436 | oxoacid metabolic process | 4 | 2 |
| GO:0044237 | cellular metabolic process | 2 | 2 |
| GO:0044238 | primary metabolic process | 2 | 2 |
| GO:0044249 | cellular biosynthetic process | 3 | 2 |
| GO:0044255 | cellular lipid metabolic process | 3 | 2 |
| GO:0044281 | small molecule metabolic process | 2 | 2 |
| GO:0044283 | small molecule biosynthetic process | 3 | 2 |
| GO:0046394 | carboxylic acid biosynthetic process | 5 | 2 |
| GO:0071704 | organic substance metabolic process | 2 | 2 |
| GO:0072330 | monocarboxylic acid biosynthetic process | 6 | 2 |
| GO:1901576 | organic substance biosynthetic process | 3 | 2 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 11 |
| GO:0004312 | fatty acid synthase activity | 5 | 11 |
| GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity | 6 | 11 |
| GO:0016740 | transferase activity | 2 | 11 |
| GO:0016746 | acyltransferase activity | 3 | 11 |
| GO:0016747 | acyltransferase activity, transferring groups other than amino-acyl groups | 4 | 11 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 317 | 319 | PF00675 | 0.310 |
| CLV_PCSK_KEX2_1 | 317 | 319 | PF00082 | 0.310 |
| DEG_SPOP_SBC_1 | 440 | 444 | PF00917 | 0.270 |
| DOC_CKS1_1 | 1 | 6 | PF01111 | 0.433 |
| DOC_MAPK_gen_1 | 213 | 221 | PF00069 | 0.264 |
| DOC_MAPK_MEF2A_6 | 125 | 132 | PF00069 | 0.251 |
| DOC_PP4_FxxP_1 | 66 | 69 | PF00568 | 0.266 |
| DOC_USP7_MATH_1 | 190 | 194 | PF00917 | 0.245 |
| DOC_USP7_MATH_1 | 385 | 389 | PF00917 | 0.245 |
| DOC_USP7_MATH_1 | 433 | 437 | PF00917 | 0.475 |
| DOC_WW_Pin1_4 | 227 | 232 | PF00397 | 0.245 |
| DOC_WW_Pin1_4 | 247 | 252 | PF00397 | 0.124 |
| DOC_WW_Pin1_4 | 364 | 369 | PF00397 | 0.362 |
| DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.265 |
| LIG_14-3-3_CanoR_1 | 360 | 365 | PF00244 | 0.288 |
| LIG_Actin_WH2_2 | 346 | 362 | PF00022 | 0.310 |
| LIG_AP2alpha_2 | 88 | 90 | PF02296 | 0.359 |
| LIG_BRCT_BRCA1_1 | 254 | 258 | PF00533 | 0.219 |
| LIG_BRCT_BRCA1_1 | 441 | 445 | PF00533 | 0.271 |
| LIG_FHA_1 | 341 | 347 | PF00498 | 0.245 |
| LIG_FHA_1 | 404 | 410 | PF00498 | 0.378 |
| LIG_FHA_1 | 450 | 456 | PF00498 | 0.283 |
| LIG_FHA_2 | 343 | 349 | PF00498 | 0.245 |
| LIG_FHA_2 | 6 | 12 | PF00498 | 0.310 |
| LIG_FHA_2 | 91 | 97 | PF00498 | 0.288 |
| LIG_LIR_Apic_2 | 28 | 34 | PF02991 | 0.190 |
| LIG_LIR_Nem_3 | 11 | 16 | PF02991 | 0.264 |
| LIG_LIR_Nem_3 | 444 | 450 | PF02991 | 0.308 |
| LIG_NRBOX | 378 | 384 | PF00104 | 0.288 |
| LIG_Pex14_2 | 32 | 36 | PF04695 | 0.378 |
| LIG_SH2_CRK | 161 | 165 | PF00017 | 0.245 |
| LIG_SH2_GRB2like | 337 | 340 | PF00017 | 0.245 |
| LIG_SH2_NCK_1 | 161 | 165 | PF00017 | 0.297 |
| LIG_SH2_SRC | 337 | 340 | PF00017 | 0.245 |
| LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.369 |
| LIG_SH2_STAT5 | 31 | 34 | PF00017 | 0.190 |
| LIG_SH2_STAT5 | 337 | 340 | PF00017 | 0.245 |
| LIG_SH3_3 | 303 | 309 | PF00018 | 0.324 |
| LIG_SH3_3 | 362 | 368 | PF00018 | 0.207 |
| LIG_SH3_3 | 64 | 70 | PF00018 | 0.304 |
| LIG_SH3_3 | 86 | 92 | PF00018 | 0.351 |
| LIG_SUMO_SIM_anti_2 | 348 | 354 | PF11976 | 0.310 |
| LIG_SUMO_SIM_par_1 | 272 | 277 | PF11976 | 0.224 |
| LIG_SUMO_SIM_par_1 | 394 | 400 | PF11976 | 0.310 |
| LIG_TRAF2_1 | 106 | 109 | PF00917 | 0.275 |
| LIG_TYR_ITIM | 159 | 164 | PF00017 | 0.245 |
| MOD_CDK_SPxxK_3 | 41 | 48 | PF00069 | 0.300 |
| MOD_CK1_1 | 252 | 258 | PF00069 | 0.313 |
| MOD_CK1_1 | 412 | 418 | PF00069 | 0.429 |
| MOD_CK2_1 | 90 | 96 | PF00069 | 0.264 |
| MOD_GlcNHglycan | 142 | 146 | PF01048 | 0.233 |
| MOD_GlcNHglycan | 20 | 23 | PF01048 | 0.272 |
| MOD_GlcNHglycan | 252 | 255 | PF01048 | 0.399 |
| MOD_GlcNHglycan | 373 | 376 | PF01048 | 0.455 |
| MOD_GSK3_1 | 141 | 148 | PF00069 | 0.394 |
| MOD_GSK3_1 | 359 | 366 | PF00069 | 0.332 |
| MOD_GSK3_1 | 403 | 410 | PF00069 | 0.308 |
| MOD_GSK3_1 | 5 | 12 | PF00069 | 0.337 |
| MOD_N-GLC_1 | 247 | 252 | PF02516 | 0.313 |
| MOD_N-GLC_1 | 407 | 412 | PF02516 | 0.481 |
| MOD_NEK2_1 | 258 | 263 | PF00069 | 0.310 |
| MOD_NEK2_1 | 370 | 375 | PF00069 | 0.264 |
| MOD_NEK2_1 | 409 | 414 | PF00069 | 0.442 |
| MOD_NEK2_1 | 454 | 459 | PF00069 | 0.291 |
| MOD_NEK2_1 | 5 | 10 | PF00069 | 0.316 |
| MOD_PKA_2 | 359 | 365 | PF00069 | 0.378 |
| MOD_Plk_1 | 141 | 147 | PF00069 | 0.286 |
| MOD_Plk_4 | 391 | 397 | PF00069 | 0.371 |
| MOD_ProDKin_1 | 227 | 233 | PF00069 | 0.245 |
| MOD_ProDKin_1 | 247 | 253 | PF00069 | 0.124 |
| MOD_ProDKin_1 | 364 | 370 | PF00069 | 0.362 |
| MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.265 |
| TRG_DiLeu_BaEn_2 | 27 | 33 | PF01217 | 0.310 |
| TRG_DiLeu_BaLyEn_6 | 22 | 27 | PF01217 | 0.266 |
| TRG_ENDOCYTIC_2 | 161 | 164 | PF00928 | 0.260 |
| TRG_ENDOCYTIC_2 | 291 | 294 | PF00928 | 0.378 |
| TRG_Pf-PMV_PEXEL_1 | 24 | 28 | PF00026 | 0.245 |
| TRG_PTS1 | 456 | 459 | PF00515 | 0.306 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I5Z2 | Leptomonas seymouri | 70% | 93% |
| A0A1X0NR83 | Trypanosomatidae | 51% | 91% |
| A0A3Q8IDZ5 | Leishmania donovani | 100% | 100% |
| A0A3R7KVG4 | Trypanosoma rangeli | 56% | 99% |
| A4HLY3 | Leishmania braziliensis | 86% | 100% |
| C9ZJB4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 50% | 92% |
| E9B4B2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
| O34340 | Bacillus subtilis (strain 168) | 38% | 100% |
| O69473 | Mycobacterium leprae (strain TN) | 36% | 100% |
| O94297 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 35% | 100% |
| P04683 | Rhizobium leguminosarum bv. viciae | 33% | 100% |
| P04684 | Rhizobium leguminosarum bv. trifolii | 34% | 100% |
| P06230 | Rhizobium meliloti (strain 1021) | 32% | 100% |
| P06231 | Rhizobium meliloti | 32% | 100% |
| P16538 | Streptomyces glaucescens | 33% | 100% |
| P16540 | Streptomyces violaceoruber | 33% | 100% |
| P23155 | Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) | 34% | 100% |
| P23902 | Hordeum vulgare | 34% | 99% |
| P39525 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 36% | 100% |
| P41175 | Streptomyces virginiae | 33% | 100% |
| P43678 | Streptomyces rimosus | 34% | 100% |
| P43710 | Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) | 36% | 100% |
| P52410 | Arabidopsis thaliana | 34% | 97% |
| P55338 | Vibrio harveyi | 38% | 100% |
| P56902 | Rhizobium meliloti (strain 1021) | 44% | 100% |
| P63457 | Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97) | 37% | 100% |
| P73283 | Synechocystis sp. (strain PCC 6803 / Kazusa) | 37% | 100% |
| P9WQD6 | Mycobacterium tuberculosis (strain CDC 1551 / Oshkosh) | 37% | 100% |
| P9WQD7 | Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) | 37% | 100% |
| Q02578 | Streptomyces cyaneus | 36% | 100% |
| Q02K94 | Pseudomonas aeruginosa (strain UCBPP-PA14) | 31% | 100% |
| Q05356 | Streptomyces halstedii | 34% | 100% |
| Q0CZH1 | Aspergillus terreus (strain NIH 2624 / FGSC A1156) | 25% | 69% |
| Q0VCA7 | Bos taurus | 40% | 100% |
| Q4Q3R4 | Leishmania major | 94% | 100% |
| Q5HHA1 | Staphylococcus aureus (strain COL) | 39% | 100% |
| Q5TKS0 | Staphylococcus aureus | 39% | 100% |
| Q6GAU2 | Staphylococcus aureus (strain MSSA476) | 39% | 100% |
| Q6GIA3 | Staphylococcus aureus (strain MRSA252) | 39% | 100% |
| Q7A6F8 | Staphylococcus aureus (strain N315) | 39% | 100% |
| Q83E37 | Coxiella burnetii (strain RSA 493 / Nine Mile phase I) | 36% | 100% |
| Q8KA28 | Buchnera aphidicola subsp. Schizaphis graminum (strain Sg) | 31% | 100% |
| Q8L3X9 | Arabidopsis thaliana | 41% | 100% |
| Q8NXE1 | Staphylococcus aureus (strain MW2) | 39% | 100% |
| Q99VA6 | Staphylococcus aureus (strain Mu50 / ATCC 700699) | 39% | 100% |
| Q9C9P4 | Arabidopsis thaliana | 36% | 85% |
| Q9D404 | Mus musculus | 39% | 100% |
| Q9KQH9 | Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961) | 38% | 100% |
| Q9NWU1 | Homo sapiens | 40% | 100% |
| V5AV31 | Trypanosoma cruzi | 54% | 98% |